Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., April 8, 2022 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported the grant of stock options to purchase an aggregate of 626,000 shares of common stock to 15 newly hired employees. These awards were approved by the Compensation Committee…

About the Author

has written 41552 stories on this site.

Copyright © 2010 Business and Corporate News.